RANDAL J KIRK Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).

Latest Insider Trading Transactions of RANDAL J KIRK

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP

Page: < prev 1 2 3 4 5 6 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 29 2018	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Sell	S	17.34	21,710	376,451	5,299,374	5.3 M to 5.3 M (-0.41 %)
Jun 29 2018	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	10% Owner	Sell	S	17.34	21,710	376,451	5,299,374	5.3 M to 5.3 M (-0.41 %)
Jun 29 2018	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,257	0	127,002
Jun 29 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,257	0	127,002
Jun 04 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	16.58	12,062	199,988	14,801,058	14.8 M to 14.8 M (+0.08 %)
Jun 04 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	16.20	49,382	799,988	1,137,273	1.1 M to 1.1 M (+4.54 %)
Jun 04 2018	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,245	0	125,745
Jun 04 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,245	0	125,745
May 02 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	18.18	11,001	199,998	14,788,996	14.8 M to 14.8 M (+0.07 %)
May 02 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	19.62	40,774	799,986	1,087,891	1 M to 1.1 M (+3.89 %)
Apr 30 2018	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,232	0	124,500
Apr 30 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,232	0	124,500
Apr 03 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	15.33	13,046	199,995	14,777,995	14.8 M to 14.8 M (+0.09 %)
Apr 03 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	16.84	47,505	799,984	1,047,117	999.6 K to 1 M (+4.75 %)
Mar 30 2018	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,220	0	123,268
Mar 30 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,220	0	123,268
Mar 01 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	13.02	15,360	199,987	14,764,949	14.7 M to 14.8 M (+0.10 %)
Mar 01 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	13.62	58,737	799,998	999,612	940.9 K to 999.6 K (+6.24 %)
Feb 28 2018	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,208	0	122,048
Feb 28 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,208	0	122,048
Feb 01 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	13.00	15,384	199,992	14,749,589	14.7 M to 14.7 M (+0.10 %)
Feb 01 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	14.71	54,384	799,989	940,875	886.5 K to 940.9 K (+6.13 %)
Jan 31 2018	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,196	0	120,840
Jan 31 2018	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,196	0	120,840
Jan 22 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Buy	P	12.50	1,000,000	12,500,000	7,782,622	6.8 M to 7.8 M (+14.74 %)
Jan 19 2018	AQB	AquaBounty Technol ...	KIRK RANDAL J	10% Owner	Option Exercise	P	3.25	1,538,461	4,999,998	1,538,461
Jan 19 2018	AQB	AquaBounty Technol ...	KIRK RANDAL J	10% Owner	Buy	P	3.25	1,538,461	4,999,998	6,700,738	5.2 M to 6.7 M (+29.80 %)
Jan 19 2018	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	3.25	1,538,461	4,999,998	1,538,461
Jan 19 2018	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Buy	P	3.25	1,538,461	4,999,998	6,700,738	5.2 M to 6.7 M (+29.80 %)
Jan 02 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	12.64	63,291	799,998	886,491	823.2 K to 886.5 K (+7.69 %)
Jan 02 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	11.52	17,361	199,999	14,734,205	14.7 M to 14.7 M (+0.12 %)
Jan 02 2018	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	11.33	1,207,980	13,686,413	14,716,844	13.5 M to 14.7 M (+8.94 %)
Dec 13 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.77	4,805	3,700	4,805
Dec 13 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.77	155,347	119,617	155,347
Dec 13 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.77	2,567,121	1,976,683	2,567,121
Dec 13 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Buy	P	0.77	4,805	3,700	10,806	6 K to 10.8 K (+80.07 %)
Dec 13 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Buy	P	0.77	155,347	119,617	349,386	194 K to 349.4 K (+80.06 %)
Dec 13 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Buy	P	0.77	2,567,121	1,976,683	5,773,626	3.2 M to 5.8 M (+80.06 %)
Dec 13 2017	FCSC	Fibrocell Science, ...	KIRK RANDAL J	10% Owner	Option Exercise	P	0.77	4,805	3,700	4,805
Dec 13 2017	FCSC	Fibrocell Science, ...	KIRK RANDAL J	10% Owner	Option Exercise	P	0.77	155,347	119,617	155,347
Dec 13 2017	FCSC	Fibrocell Science, ...	KIRK RANDAL J	10% Owner	Option Exercise	P	0.77	2,567,121	1,976,683	2,567,121
Dec 13 2017	FCSC	Fibrocell Science, ...	KIRK RANDAL J	10% Owner	Buy	P	0.77	4,805	3,700	10,806	6 K to 10.8 K (+80.07 %)
Dec 13 2017	FCSC	Fibrocell Science, ...	KIRK RANDAL J	10% Owner	Buy	P	0.77	155,347	119,617	349,386	194 K to 349.4 K (+80.06 %)
Dec 13 2017	FCSC	Fibrocell Science, ...	KIRK RANDAL J	10% Owner	Buy	P	0.77	2,567,121	1,976,683	5,773,626	3.2 M to 5.8 M (+80.06 %)
Dec 04 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	13.64	14,662	199,990	13,508,864	13.5 M to 13.5 M (+0.11 %)
Dec 04 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	12.65	63,241	799,999	823,200	760 K to 823.2 K (+8.32 %)
Nov 30 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,172	0	118,460
Nov 30 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,172	0	118,460
Nov 01 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	16.35	12,232	199,993	13,494,202	13.5 M to 13.5 M (+0.09 %)
Nov 01 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	17.99	44,469	799,997	759,959	715.5 K to 760 K (+6.22 %)
Nov 01 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,161	0	117,288
Nov 01 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,161	0	117,288
Oct 02 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	19.01	10,520	199,985	13,481,970	13.5 M to 13.5 M (+0.08 %)
Oct 02 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	19.37	41,300	799,981	715,490	674.2 K to 715.5 K (+6.13 %)
Sep 29 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,149	0	116,127
Sep 29 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,149	0	116,127
Sep 01 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	19.73	10,136	199,983	13,471,450	13.5 M to 13.5 M (+0.08 %)
Sep 01 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	18.63	42,941	799,991	674,190	631.2 K to 674.2 K (+6.80 %)
Aug 31 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,138	0	114,978
Aug 31 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,138	0	114,978
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	P	10.00	80,292	802,920	80,292
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	C	0.00	162,696	0	0
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	P	10.00	160,585	1,605,850	160,585
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	C	0.00	325,393	0	0
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	P	10.00	160,585	1,605,850	160,585
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	C	0.00	325,393	0	0
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	0.00	162,696	0	271,824	109.1 K to 271.8 K (+149.09 %)
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	0.00	325,393	0	515,997	190.6 K to 516 K (+170.72 %)
Aug 30 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	0.00	325,393	0	543,649	218.3 K to 543.6 K (+149.09 %)
Aug 14 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Buy	P	18.85	132,625	2,499,981	6,782,622	6.6 M to 6.8 M (+1.99 %)
Aug 01 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	21.59	9,263	199,988	13,461,314	13.5 M to 13.5 M (+0.07 %)
Aug 01 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	23.13	34,587	799,997	631,249	596.7 K to 631.2 K (+5.80 %)
Jul 31 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,127	0	113,840
Jul 31 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,127	0	113,840
Jul 26 2017	AQB	AquaBounty Technol ...	KIRK RANDAL J	10% Owner	Buy	J	0.00	124,609	0	124,609	0 to 124.6 K
Jul 26 2017	AQB	AquaBounty Technol ...	KIRK RANDAL J	10% Owner	Buy	J	0.00	121,231	0	200,519	79.3 K to 200.5 K (+152.90 %)
Jul 26 2017	AQB	AquaBounty Technol ...	KIRK RANDAL J	10% Owner	Sell	J	0.00	338,816	0	0	338.8 K to 0 (-100.00 %)
Jul 26 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Buy	J	0.00	124,609	0	124,609	0 to 124.6 K
Jul 26 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Buy	J	0.00	121,231	0	200,519	79.3 K to 200.5 K (+152.90 %)
Jul 26 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Sell	J	0.00	338,816	0	0	338.8 K to 0 (-100.00 %)
Jul 26 2017	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	J	0.00	2,327,603	0	2,327,603	0 to 2.3 M
Jul 26 2017	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	J	0.00	2,264,483	0	5,321,084	3.1 M to 5.3 M (+74.09 %)
Jul 26 2017	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Sell	J	0.00	6,328,853	0	0	6.3 M to 0 (-100.00 %)
Jul 26 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Buy	J	0.00	8,325,000	0	8,325,000	0 to 8.3 M
Jul 26 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Buy	J	0.00	8,099,238	0	13,452,051	5.4 M to 13.5 M (+151.31 %)
Jul 26 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Sell	J	0.00	22,636,052	0	0	22.6 M to 0 (-100.00 %)
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	C	0.00	42,941	0	0
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	C	0.00	42,941	0	0
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	P	0.00	160,585	0	160,585
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	C	0.00	42,941	0	0
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	P	0.00	321,170	0	321,170
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	C	0.00	85,882	0	0
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Option Exercise	P	0.00	321,170	0	321,170
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	0.00	1,431	0	27,651	26.2 K to 27.7 K (+5.46 %)
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	0.00	1,431	0	109,128	107.7 K to 109.1 K (+1.33 %)
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	15.00	70,526	1,057,890	107,697	37.2 K to 107.7 K (+189.73 %)
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	0.00	1,431	0	190,604	189.2 K to 190.6 K (+0.76 %)
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	15.00	141,052	2,115,780	189,173	48.1 K to 189.2 K (+293.12 %)
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	0.00	2,862	0	218,256	215.4 K to 218.3 K (+1.33 %)
Jul 03 2017	TBIO	Precipio, Inc.	KIRK RANDAL J	10% Owner	Buy	C	15.00	141,052	2,115,780	215,394	74.3 K to 215.4 K (+189.73 %)
Jun 30 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	24.09	8,302	199,995	5,352,813	5.3 M to 5.4 M (+0.16 %)
Jun 30 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	22.82	35,056	799,978	596,662	561.6 K to 596.7 K (+6.24 %)
Jun 30 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,115	0	112,713
Jun 30 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,115	0	112,713
Jun 12 2017	TBIO	TRANSGENOMIC INC	KIRK RANDAL J	10% Owner	Sell	S	1.00	108,000	108,000	786,613	894.6 K to 786.6 K (-12.07 %)
Jun 12 2017	TBIO	TRANSGENOMIC INC	KIRK RANDAL J	10% Owner	Sell	S	1.00	395,000	395,000	1,115,135	1.5 M to 1.1 M (-26.16 %)
Jun 12 2017	TBIO	TRANSGENOMIC INC	KIRK RANDAL J	10% Owner	Sell	S	1.00	682,000	682,000	1,443,654	2.1 M to 1.4 M (-32.08 %)
Jun 12 2017	TBIO	TRANSGENOMIC INC	KIRK RANDAL J	10% Owner	Sell	S	1.00	790,000	790,000	2,230,267	3 M to 2.2 M (-26.16 %)
Jun 02 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	21.32	9,380	199,982	5,344,511	5.3 M to 5.3 M (+0.18 %)
Jun 02 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	25.67	31,164	799,980	561,606	530.4 K to 561.6 K (+5.88 %)
Jun 01 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,104	0	111,598
Jun 01 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,104	0	111,598
May 15 2017	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Option Exercise	M	10.37	10,000	103,700	0
May 15 2017	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Buy	M	10.37	10,000	103,700	3,562,388	3.6 M to 3.6 M (+0.28 %)
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	X	0.80	250,000	200,000	0
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Sell	S	2.54	1,881	4,778	85,397	87.3 K to 85.4 K (-2.16 %)
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Sell	S	2.70	13,893	37,511	87,278	101.2 K to 87.3 K (-13.73 %)
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Sell	S	2.97	2,278	6,766	101,171	103.4 K to 101.2 K (-2.20 %)
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Sell	S	2.54	9,695	24,625	440,418	450.1 K to 440.4 K (-2.15 %)
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Sell	S	2.70	71,607	193,339	450,113	521.7 K to 450.1 K (-13.73 %)
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Sell	S	2.97	11,739	34,865	521,720	533.5 K to 521.7 K (-2.20 %)
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Sell	S	4.01	49,875	199,999	533,459	583.3 K to 533.5 K (-8.55 %)
May 08 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Buy	X	0.80	250,000	200,000	583,334	333.3 K to 583.3 K (+75.00 %)
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Option Exercise	X	0.80	250,000	200,000	0
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Sell	S	2.54	1,881	4,778	85,397	87.3 K to 85.4 K (-2.16 %)
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Sell	S	2.70	13,893	37,511	87,278	101.2 K to 87.3 K (-13.73 %)
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Sell	S	2.97	2,278	6,766	101,171	103.4 K to 101.2 K (-2.20 %)
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Sell	S	2.54	9,695	24,625	440,418	450.1 K to 440.4 K (-2.15 %)
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Sell	S	2.70	71,607	193,339	450,113	521.7 K to 450.1 K (-13.73 %)
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Sell	S	2.97	11,739	34,865	521,720	533.5 K to 521.7 K (-2.20 %)
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Sell	S	4.01	49,875	199,999	533,459	583.3 K to 533.5 K (-8.55 %)
May 08 2017	DOR	SOLIGENIX, INC.	KIRK RANDAL J	10% Owner	Buy	X	0.80	250,000	200,000	583,334	333.3 K to 583.3 K (+75.00 %)
May 08 2017	GYHT	HALOZYME THERAPEUT ...	KIRK RANDAL J	Director	Grant	A	0.00	14,135	0	3,552,388	3.5 M to 3.6 M (+0.40 %)
May 02 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,094	0	110,494
May 02 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,094	0	110,494
May 02 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	20.84	9,596	199,981	5,335,131	5.3 M to 5.3 M (+0.18 %)
May 02 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	19.67	40,671	799,999	530,442	489.8 K to 530.4 K (+8.30 %)
Apr 03 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	19.82	10,090	199,984	5,325,535	5.3 M to 5.3 M (+0.19 %)
Apr 03 2017	XON	INTREXON CORP	KIRK RANDAL J	Chief Executive Off ...	Grant	A	21.16	37,807	799,996	489,771	452 K to 489.8 K (+8.37 %)
Mar 31 2017	XON	INTREXON CORP	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,083	0	109,400
Mar 31 2017	ZIOP	ZIOPHARM ONCOLOGY ...	KIRK RANDAL J	Director	Option Exercise	J	0.00	1,083	0	109,400
Mar 10 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.85	1,496,529	1,265,914	1,496,529
Mar 10 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.85	2,250,594	1,903,777	2,250,594
Mar 10 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.85	3,867	3,271	3,867
Mar 10 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.85	136,634	115,579	136,634
Mar 10 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.78	1,161	901	1,496,529
Mar 10 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.78	1,746	1,354	2,250,594
Mar 10 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.78	3	2	3,867
Mar 10 2017	XON	INTREXON CORP	KIRK RANDAL J	10% Owner	Option Exercise	P	0.78	106	82	136,634
Mar 10 2017	FCSC	Fibrocell Science, ...	KIRK RANDAL J	10% Owner	Option Exercise	P	0.85	1,496,529	1,265,914	1,496,529

Page: < prev 1 2 3 4 5 6 next >